China Pharma Holdings IncCPHI
Price$0.65

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $4.1M-8.9% YoYTTM through 31 Dec 2025
Net Income -$3.2MTTM through 31 Dec 2025
Free Cash Flow $148KTTM through 31 Dec 2025

Margins

Current
Gross Margin-2.4%
Operating Margin-78.0%
Net Margin-77.8%

Returns

-14.0%ROE
-10.3%ROA

Balance Sheet Health

Debt / Equity0.17x
Current Ratio0.32x
Net Debt$3.5M
Cash & Equivalents$345.1K

Quality Metrics

FCF Margin3.6%
Earnings-Beat Rate33.3%

Dividend

No dividend

Segment Performance

No segment data available.

All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.